Imugene (ASX: IMU) - The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
Вставка
- Опубліковано 17 лис 2024
- We have the Imugene CEO (ASX: IMU) Leslie Chong joining us on the ASX Investor channel today. We discuss Imugene’s recent growth in our latest ASX CEO Interview and their journey as a leading ASX Biotech company developing a range of cancer immunotherapy solutions to impact lives globally.
Imugene (IMU) have soared as an ASX Growth Stock- delivering outstanding growth & clinical progress with their B-Cell immunotherapy treatments (HER-Vaxx & PD1-Vaxx) while progressing their oncolytic viruses (CF33 & OnCARlytics).
Imugene (IMU) is an exciting ASX Growth Stock leading the way as an ASX Biotech company with the ability to develop cancer treatments that will make a difference in many lives globally for those suffering from cancer.
Imugene is attracting a range of ASX growth stock investors attention with a significant uplift in the ASX: IMU share price on the back of their clinical progress for their B-Cell immunotherapy treatments & developments with their oncolytic virus treatments.
ASX: IMU CEO Leslie Chong provides a range of insights throughout this wide reaching ASX CEO interview exploring the Imugene (IMU) opportunity with the focus on continuing to scale the Imugene offering as an ASX Biotech company.
A big thank you to Leslie Chong for joining us on the ASX Investor channel to unpack the ASX: IMU story. We look forward to touching base again in the future to hear more about Imugene and discussing news announcements as ASX: IMU continues to develop out their cancer immunotherapy portfolio.
Imugene (IMU) is a leading ASX Biotech company and with Imugene’s focus on developing a portfolio of immunotherapy treatments - there is a lot of excitement surrounding this ASX Biotech growth stock.
#Imugene #ASXIMU #Biotech
-------------------------------------------------------------------------------
Discord Link: / discord
Twitter: / asxinvest
-------------------------------------------------------------------------------
Welcome to the ASX Investor channel 👋
Our mission is to find and analyse the best potential ASX growth stocks and talk all things investing and the economy with daily videos 📈
We break down economics and stock market trends, making them easy to access & understand for everyone.
Please click subscribe to stay up to date with all of the future daily videos -
Thank you for joining and welcome to the community!
✔️ Subscribe: / asxinvestor
-------------------------------------------------------------------------------
*Disclaimer:
I am not a financial advisor - The information on this channel is NOT financial advice.
These videos are designed purely for educational purposes and should serve as a starting spot to do your own research from.
Nothing contained in this video should be construed as an offer, solicitation, or recommendation to buy or sell any investment or security, and is not designed to provide you with an investment strategy. The information provided should not be relied upon as the basis for making any purchase, sale or investment decision regarding any stock or asset.
These videos merely express my opinion, which is based on information obtained from sources believed to be accurate at the time of discussion.
ASX Investor is not liable for any loss caused, whether due to negligence or because of reliance on, the information provided directly or indirectly, in this video.
What are your thoughts on Imugene and where do you think ASX: IMU heads from here?! 🚀
Please Like & Subscribe to stay up to date with our daily videos 🙏
Quite keen! Bought a parcel at 9c, and definitely holding long term. Only question is, is it too high now to buy more? Unsure.
Will definitely be interesting to see where the IMU journey goes. Has been a rapid uplift for Imugene but still have plenty of potential newsflow on the horizon. Will be watching to see where the story heads from here 😊
@@aniorvs4780 biotech usually has very high risk. I wouldn't buy when the share prices spike high because of exciting news, coz this usually go transiently.
@@aniorvs4780 bought it at 2c
Lotta insider selling and 5B shares circulating SMH
As an IMU investor for the past 6+ years, this is my favourite interview with Leslie ever. Well done to ASX Investor and of course the incomparable Ms Chong. Well done to the who team of IMUers including Leslie, Paul and Nick. What an exciting journey it has been.
Loving the passion in your voice Leslie and you’ve always had the knack of simplifying the message for the rest of us.
Cheers,
Scott C.
Thank you so much Scott for your feedback - it truly is appreciated and congratulations for what would have been a phenomenal past 6 years with IMU.
It's amazing to hear that you found this interview so valuable and you are correct, the entire IMU team is incredible, they are building a special project there. Will be watching to see where the Imugene story heads from here 😊
Truly amazing! I mean, these people deserve a Nobel prize! God bless them!
They are on an incredible mission and if successful, truly will have the ability to impact so many lives globally 👏
I bought in at 5c in Oct 20. Very promising medical tech, and terrific management and company. At $300m MC is just the start, and becomes a real TO target for big pharma.
Congratulations on some phenomenal returns within your first year of investment. Will be fascinating to see where the Imugene story heads next from here with a couple of major potential newsflow announcements ahead in the next 6 months 😊
50c?
Wow wow wow what a fantastic ceo and inspirational person
Agreed! Leslie has an incredible passion & drive to make a difference and it will be incredible to watch the IMU story moving forward 😊
Great CEO interview mate. All your hip and excitement this week was so so true. Keep up the hard work 👍
Amazing opportunity ahead of IMU.
Thank you so much mate! Always great to hear that the interviews are well received and appreciated 🙏
Great interview and great futur for imugene. Patients and shareholder will be well reward. Go imu go...
Thanks so much mate - Glad to hear you enjoyed the interview 😊
IMU has an exciting journey ahead!
This is amazing to the future of cancer cures, so many loved ones will benefit from this.
Great to get aboard and support this company now, before it goes mainstream!
The scope of impact that could be made for those experiencing cancer around the world if IMU is successful is absolutely incredible.
Will definitely be watching to see where the journey heads 😊
Great interview. Your interview manner is genuine inquiry, I enjoy it. Such an articulate CEO. Fascinating concepts. Well done for creating and sharing this information.
Thank you so much mate - really appreciate the feedback! Glad to hear the interviews are valuable resources.
Agreed, Leslie provided incredible insights & her evident passion when discussing the mission is truly inspiring 😊
Thanks for the great interview.
I have been holding IMU for a little over 12 months. It has been great watching the progress. Leslie is amazing. It is a long hard slog to get through all the trials, but fantastic if successful.
I use the basket approach to my Bio Tech investments. Many bio techs seem to follow the life cycle of a mine share price graph. I am quite happy to hold for the long term even when they go very red. I get sad when I have to sell to balance CGT. I think the market has great difficulty in valuing the bio techs.
Thanks Matthew - I know you have mentioned that IMU is one you have been holding over this past period so I'm glad to hear you enjoyed the interview 😊
100% agree with you re: the markets difficulty in valuing biotech's, on the ASX in particular there seems to be a huge variance in knowledge/understanding of the sector and the key drivers within it. I think your strategy & the logic behind it makes sense, will definitely be interesting to see where IMU heads from here!
You are giving us a hint to stay invested.
Yes, Looking forward for the next 6 months. Great interview. Thank you.
Definitely looks like an exciting time up ahead for the Imugene story!
Will be watching to see where the next 6 months (and beyond) have in store 😊
I remember investing in IMU back in 2018 when it was 1.8c, sold for a few pips I should of just believed in Leslie! She did a great presentation in Sydney as well but the shareprice was stagnate for so long until recently
Ahhhh I know the feeling too well mate, I think every trader/investor has a few of those stories about 'the ones that got away'.
Will be interesting to see where the story heads after a phenomenal past 6 months - hope you enjoyed the interview mate! 😊
Awesome interview 💪
Thanks so much brother!
Hope you had a great weekend 😊
Another great video, can you do a video on how you approach ceo's, I'm curious on how you go about contacting them and how you prep for interview, and what they want in return
Thank you so much - I'm glad you enjoyed the video 🙌
Re: Reaching out, it's different for every interview but just try to do as much research as possible into all of the companies and ask questions that I believe the broader audience base will enjoy learning about 😊
Great interview mate
Thanks mate!
Great to hear you enjoyed it and hope you enjoyed a good weekend 😊
Great video 👌
Thanks so much mate! Glad you enjoyed it 🙌
What about Chimeric CHM? Something to look into.
Personally haven't dove into Chimeric so don't have any thoughts I can share at this time.
Hopefully you enjoyed the interview mate 😊
How’s your two favourite stocks brain chip and weebit nano going?
It's obviously been an incredible past year for both BRN & WBT.
Would never have anticipated they would have had such a phenomenal year but to see Brainchip +494% and Weebit +485% over the past 12 months speaks to the amazing journey of development they've been on.
Of course however share price's are not in isolation an indication of progression so for me, my focus is much more on milestones and with BRN moving towards volume manufacturing & most significantly the finalising of an IP licensing agreement with a Tier 1 global semiconductor manufacturer it definitely looks like an exciting journey ahead 😊
id love you to compare IMU with Qbiotics soon ASX investor. i hold both companies
Hey mate,
Just had a quick search and can see Qbiotics is currently unlisted. It's not a company I'm not familiar with so can't provide any thoughts, however I hope that you enjoyed this video and it helped provide some insights into the IMU story 😊
@@ASXInvestor love your work
hervaxx itself worths way over the $2B the current MC
Amazing portfolio with great potentials
I hope IMU/biotech gets more grants supported from the government on top of the current R&D
Otherwise IMU will have to sell one or two from their pipeline (likely Hervaxx) to the bigpharm like very soon, it won’t sell at cheap.
But if they can sustain the fundings in the long run, then no brainer to be the next CSL
We are talking about a cancer cure here
The multi-faceted portfolio is definitely an exciting component of the Imugene offering.
Will be very interesting to see how the commercial activity starts playing out with big pharma if/when it does come through.
Incredible portfolio as you mentioned, will definitely be watching the journey and is a cause that everybody will be hoping they succeed with 😊
Are they actually making money yet
They are currently pre-commercialisation in the clinical phase of their development.
They have a number of treatment candidates with their HER-Vaxx treatment the most clinically advanced in Phase II at the moment 😊